Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990;30(Suppl 1):49S–53S. doi: 10.1111/j.1365-2125.1990.tb05468.x

β-adrenoceptor control of immune function in congestive heart failure

A S Maisel, M C Michel
PMCID: PMC1368098  PMID: 2176529

Abstract

1 We have determined the number of β-adrenoceptors and the isoprenaline-stimulated cAMP generation in lymphocyte subsets. The in vitro β-adrenergic sensitivity was greatest in Tsuppressor/cytotoxic- and natural killer cells and smallest in Thelper- and B-cells. B lymphocytes appear to have a poor receptor coupling to adenylate cyclase as they have many β-adrenoceptors but generate only little cAMP in response to isoprenaline.

2 A 7 day treatment of healthy volunteers with terbutaline decreased the number of circulating cells in those lymphocyte subsets with a high in vitro sensitivity to β-adrenoceptor stimulation (i.e. Tsuppressor/cytotoxic- and natural killer cells) but not in those with a poor in vitro sensitivity (i.e. Thelper- and B-lymphocytes).

3 Similar alterations of circulating lymphocyte subsets were found in patients with congestive heart failure (CHF). These alterations were not related to the aetiology of CHF but to its severity and could be correlated with plasma catecholamine levels.

4 We conclude that prolonged exposure to β-adrenoceptor agonists or enhanced sympathetic activity can decrease the number of circulating lymphocytes with an increase in the Thelper-/Tsuppressor/cytotoxic-cell ratio.

Keywords: heart failure, β-adrenoceptors, immune system, lymphocytes

Full text

PDF
51S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourne H. R., Lichtenstein L. M., Melmon K. L., Henney C. S., Weinstein Y., Shearer G. M. Modulation of inflammation and immunity by cyclic AMP. Science. 1974 Apr 5;184(4132):19–28. doi: 10.1126/science.184.4132.19. [DOI] [PubMed] [Google Scholar]
  2. Brodde O. E., Engel G., Hoyer D., Bock K. D., Weber F. The beta-adrenergic receptor in human lymphocytes: subclassification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci. 1981 Nov 23;29(21):2189–2198. doi: 10.1016/0024-3205(81)90490-2. [DOI] [PubMed] [Google Scholar]
  3. Cohn J. N., Rector T. S. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988 Jul 11;62(2):25A–30A. doi: 10.1016/s0002-9149(88)80081-x. [DOI] [PubMed] [Google Scholar]
  4. DeBlasi A., Maisel A. S., Feldman R. D., Ziegler M. G., Fratelli M., DiLallo M., Smith D. A., Lai C. Y., Motulsky H. J. In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion. J Clin Endocrinol Metab. 1986 Oct;63(4):847–853. doi: 10.1210/jcem-63-4-847. [DOI] [PubMed] [Google Scholar]
  5. Felten D. L., Felten S. Y., Bellinger D. L., Carlson S. L., Ackerman K. D., Madden K. S., Olschowki J. A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev. 1987 Dec;100:225–260. doi: 10.1111/j.1600-065x.1987.tb00534.x. [DOI] [PubMed] [Google Scholar]
  6. Francis G. S. Neuroendocrine manifestations of congestive heart failure. Am J Cardiol. 1988 Jul 11;62(2):9A–13A. doi: 10.1016/s0002-9149(88)80078-x. [DOI] [PubMed] [Google Scholar]
  7. Kammer G. M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today. 1988 Jul-Aug;9(7-8):222–229. doi: 10.1016/0167-5699(88)91220-0. [DOI] [PubMed] [Google Scholar]
  8. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  9. Mahan L. C., Insel P. A. Use of superoxide dismutase and catalase to protect catecholamines from oxidation in tissue culture studies. Anal Biochem. 1984 Jan;136(1):208–216. doi: 10.1016/0003-2697(84)90327-0. [DOI] [PubMed] [Google Scholar]
  10. Maisel A. S., Fowler P., Rearden A., Motulsky H. J., Michel M. C. A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin Pharmacol Ther. 1989 Oct;46(4):429–439. doi: 10.1038/clpt.1989.161. [DOI] [PubMed] [Google Scholar]
  11. Maisel A. S., Knowlton K. U., Fowler P., Rearden A., Ziegler M. G., Motulsky H. J., Insel P. A., Michel M. C. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest. 1990 Feb;85(2):462–467. doi: 10.1172/JCI114460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maisel A. S., Motulsky H. J. Receptor redistribution does not accompany terbutaline-induced down regulation of beta-adrenergic receptors on human mononuclear leukocytes. Clin Pharmacol Ther. 1987 Jul;42(1):100–106. doi: 10.1038/clpt.1987.115. [DOI] [PubMed] [Google Scholar]
  13. Mueller H., Motulsky H. J., Sklar L. A. The potency and kinetics of the beta-adrenergic receptors on human neutrophils. Mol Pharmacol. 1988 Sep;34(3):347–353. [PubMed] [Google Scholar]
  14. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988 Apr;77(4):721–730. doi: 10.1161/01.cir.77.4.721. [DOI] [PubMed] [Google Scholar]
  15. Phillips J. H., Lanier L. L. Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen. J Immunol. 1986 Mar 1;136(5):1579–1585. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES